Trials / Not Yet Recruiting
Not Yet RecruitingNCT07170046
Predictive Value of CEA and ctDNA in Lung Cancer Recurrence
Predictive Value of CEA and ctDNA for Postoperative Recurrence in Patients With High CEA Sensitivity Lung Cancer
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate the predictive value of CEA levels for postoperative recurrence in the highly sensitive CEA lung cancer patients and to explore whether the dynamic changes of postoperative CEA and MRD in this population are related.This study was carried out to accurately predict the recurrence time, save the time and cost of changing the intervention strategy, and provide more personalized treatment for patients.
Detailed description
This study will collect two groups of cohorts: prospective and retrospective.
Conditions
Timeline
- Start date
- 2025-09-15
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2025-09-12
- Last updated
- 2025-09-12
Source: ClinicalTrials.gov record NCT07170046. Inclusion in this directory is not an endorsement.